|
|
||||||||
Ann Thorac Surg 1997;63:1737-1741
© 1997 The Society of Thoracic Surgeons
Department of Thoracic and Cardiovascular Surgery, Pitie's Hospital, Paris, France
Accepted for publication December 26, 1996.
Background. In this report, we reviewed 247 patients who underwent operation by our team for active native valve endocarditis between January 1979 and December 1993.
Methods. There were 201 male and 46 female patients (mean age, 45.4 ± 6 years). The aortic valve was involved in 163 cases, the mitral valve in 36 cases, both mitral and aortic valves in 44 cases, and the tricuspid valve alone in 4 cases. The most common microorganisms were streptococci. Univariate Pearson (
2 test) and multivariate (stepwise logistic regression [BMDPLR]) analyses were used to identify significant predictors of operative mortality, reoperation, and recurrent endocarditis. Cox proportional hazards regression model was used to study late survival.
Results. Operative mortality was 7.6% (n = 19). Increased age, cardiogenic shock at the time of operation, insidious illness, and greater thoracic ratio (>0.5) were the predominant risk factors; the length of antibiotic therapy appeared to have no influence. Two hundred thirteen patients were followed up. Median follow-up time was 6 years (range, 2 to 19 years). Overall survival rate (operative mortality excluded) was 71.3% ± 3.8% at 9 years. Increased age, preoperative neurologic complications, cardiogenic shock at the time of operation, shorter duration of the illness, insidious illness before the operation, and mitral valve endocarditis were the predominant risk factors for late mortality. The probability of freedom from reoperation (operative mortality included) was 73.3% ± 4.2% at 8 years; risk factors were younger age and aortic valve endocarditis. The rate of prosthetic valve endocarditis was 7%. No significant risk factor was found.
Conclusions. Increased age, insidious illness, and hemodynamic failure are the main risk factors for operative mortality. Long-term survival is good except for patients with preoperative neurologic complications and mitral valve endocarditis.
This article has been cited by other articles:
![]() |
T. Gudbjartsson, T. Absi, and S. Aranki Mitral Valve Replacement Card. Surg. Adult, January 1, 2008; 3(2008): 1031 - 1068. [Full Text] |
||||
![]() |
E. M. Delmo Walter, M. Musci, N. Nagdyman, M. Hubler, F. Berger, and R. Hetzer Mitral Valve Repair for Infective Endocarditis in Children Ann. Thorac. Surg., December 1, 2007; 84(6): 2059 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Colli, R. Campodonico, and T. Gherli Early Switch From Vancomycin to Oral Linezolid for Treatment of Gram-Positive Heart Valve Endocarditis Ann. Thorac. Surg., July 1, 2007; 84(1): 87 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kamalakannan, R. M. Pai, L. B. Johnson, J. M. Gardin, and L. D. Saravolatz Epidemiology and Clinical Outcomes of Infective Endocarditis in Hemodialysis Patients Ann. Thorac. Surg., June 1, 2007; 83(6): 2081 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. de Kerchove, J.-L. Vanoverschelde, A. Poncelet, D. Glineur, J. Rubay, F. Zech, P. Noirhomme, and G. El Khoury Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 592 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ruttmann, J. Willeit, H. Ulmer, O. Chevtchik, D. Hofer, W. Poewe, G. Laufer, and L. C. Muller Neurological Outcome of Septic Cardioembolic Stroke After Infective Endocarditis Stroke, August 1, 2006; 37(8): 2094 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
B D Prendergast The changing face of infective endocarditis Heart, July 1, 2006; 92(7): 879 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Gammie, S. M. O'Brien, B. P. Griffith, and E. D. Peterson Surgical Treatment of Mitral Valve Endocarditis in North America Ann. Thorac. Surg., December 1, 2005; 80(6): 2199 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ruttmann, C. Legit, G. Poelzl, S. Mueller, O. Chevtchik, M. Cottogni, H. Ulmer, O. Pachinger, G. Laufer, and L. C. Mueller Mitral valve repair provides improved outcome over replacement in active infective endocarditis J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 765 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zegdi, M. Debieche, C. Latremouille, D. Lebied, C. Chardigny, J.-M. Grinda, S. Chauvaud, A. Deloche, A. Carpentier, and J.-N. Fabiani Long-Term Results of Mitral Valve Repair in Active Endocarditis Circulation, May 17, 2005; 111(19): 2532 - 2536. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murashita, H. Sugiki, Y. Kamikubo, and K. Yasuda Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1104 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Iung, J. Rousseau-Paziaud, B. Cormier, E. Garbarz, O. Fondard, E. Brochet, C. Acar, J.-P. Couetil, U. Hvass, and A. Vahanian Contemporary results of mitral valve repair for infective endocarditis J. Am. Coll. Cardiol., February 4, 2004; 43(3): 386 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Granowitz and D. L. Longworth Risk Stratification and Bedside Prognostication in Infective Endocarditis JAMA, April 16, 2003; 289(15): 1991 - 1993. [Full Text] [PDF] |
||||
![]() |
T. Gudbjartsson, S. Aranki, and L. H. Cohn Mechanical/Bioprosthetic Mitral Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 951 - 986. [Full Text] |
||||
![]() |
E. Mylonakis and S. B. Calderwood Infective Endocarditis in Adults N. Engl. J. Med., November 1, 2001; 345(18): 1318 - 1330. [Full Text] [PDF] |
||||
![]() |
J M Guerra, M P Tornos, G Permanyer-Miralda, B Almirante, M Murtra, and J Soler-Soler Long term results of mechanical prostheses for treatment of active infective endocarditis Heart, July 1, 2001; 86(1): 63 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillinov, R. Diaz, E. H. Blackstone, G. B. Pettersson, J. F. Sabik, B. W. Lytle, and D. M. Cosgrove III Double valve endocarditis Ann. Thorac. Surg., June 1, 2001; 71(6): 1874 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aagaard and P. V. Andersen Acute endocarditis treated with radical debridement and implantation of mechanical or stented bioprosthetic devices Ann. Thorac. Surg., January 1, 2001; 71(1): 100 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Heiro, J. Nikoskelainen, E. Engblom, E. Kotilainen, R. Marttila, and P. Kotilainen Neurologic Manifestations of Infective Endocarditis: A 17-Year Experience in a Teaching Hospital in Finland Arch Intern Med, October 9, 2000; 160(18): 2781 - 2787. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Baumgartner, B. O. Omari, J. M. Robertson, R. J. Nelson, A. Pandya, A. Pandya, and J. C. Milliken Annular abscesses in surgical endocarditis: anatomic, clinical, and operative features Ann. Thorac. Surg., August 1, 2000; 70(2): 442 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alexiou, S. M. Langley, H. Stafford, J. A. Lowes, S. A. Livesey, and J. L. Monro Surgery for active culture-positive endocarditis: determinants of early and late outcome Ann. Thorac. Surg., May 1, 2000; 69(5): 1448 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-B. Edwards, C. P. Ratnatunga, C. J. Dore, and K. M. Taylor Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: a study from the UK heart valve registry Eur. J. Cardiothorac. Surg., August 1, 1999; 14(2): 156 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bauernschmitt, H. G. Jakob, C.-F. Vahl, R. Lange, and S. Hagl Operation for Infective Endocarditis: Results After Implantation of Mechanical Valves Ann. Thorac. Surg., February 1, 1998; 65(2): 359 - 364. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |